Staar Surgical Co (STAA) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jul 03 2026 to Jun 27 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Staar Surgical Co  (NASDAQ: STAA)


Staar Surgical Co's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Staar Surgical Co's ROA in the second quarter of 2026?
Staar Surgical Co achieved a return on average assets (ROA) of 0.83 % in its second quarter of 2026, this is above STAA's average return on assets of -2.13%.
Staar Surgical Co assets over the 12 months ending in its second quarter of 2026 are valued at $461 million

ROA has improved compared to -4.66% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 203 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jul 03 2026 quarter, so far to 2964, from total ROA ranking in the first quarter of 2026 at 3999.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jul 03 2026)
II. Quarter		 (Apr 03 2026)
I. Quarter		 (Jan 02 2026)
IV. Quarter		 (Sep 26 2025)
III. Quarter		 (Jun 27 2025)
II. Quarter
Y / Y Total Assets Change 8.55 % -1.37 % -3.3 % -9 % -8.87 %
Y / Y Net Income Change - - - -10.98 % -
Net Income (TTM) in million 4 -21 -80 -96 -95
Return On Assets (TTM) 0.83 % -4.66 % -17.76 % -21.1 % -20.35 %
STAA's Total Ranking # 2964 # 3999 # 3562 # 3573 # 3473
Total Assets (TTM) in million 475 451 460 456 438
Seq. Total Assets Change 5.34 % -1.91 % 0.78 % 4.24 % -4.28 %
Seq. Net Income Change 54.78 % - - - -

STAA's 5 Years Annual ROA >> Back to STAA Management Effectiveness >> Compare STAA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 66
Sector # 204
Overall # 2293

Return On Assets Statistics
High Average Low
10.31 %
-2.13 %
-20.71 %
(Sep 30 2022)   (Sep 26 2025)





Financial Statements
Staar Surgical Co's Assets $ 475 million STAA's Balance sheet
Staar Surgical Co's Income $ 8 million Quarterly STAA's Income Statement
STAA's Income by Division See STAA's Income by Division



Annual Return On Assets (Jan 02 2026)
FY 2025		 (Dec 27 2024)
FY 2024		 (Dec 29 2023)
FY 2023		 (Dec 30 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -5.03 % 4.17 % 17.83 % 22.5 % 26.28 %
Total Assets in million 452 476 457 388 316
Y / Y Net Income Change - - -44.92 % 58.18 % 314.36 %
Net Income in million -80 -20 21 39 25
Annual Return On Assets -17.81 % -4.25 % 4.68 % 10 % 7.75 %

STAA's 5 Years Annual ROA >> Back to STAA Management Effectiveness >> Compare STAA ROA to its Competitors



More Return On Assets Ratios
STAA's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
STAA's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for STAA's Competitors
Subscribers only: Roa for Staar Surgical Co's Suppliers
Subscribers only: Return On Assets for STAA's Customers

You may also want to know
STAA's Roi STAA's Inventory Turnover Ratio STAA's Growth Rates STAA's Dividend Comparisons
STAA's Profitability Ratios STAA's Asset Turnover Ratio STAA's Dividend Growth
STAA's Roe STAA's Valuation Ratios STAA's Financial Strength Ratios STAA's Dividend Payout Ratio



Companies with similar Return On Assets at Jul 03 2026, within Healthcare Sector ROA
Bio rad Laboratories Inc   2.21 %
Pfizer Inc  2.12 %
Mimedx Group Inc   1.99 %
Revvity Inc  1.97 %
Alkermes Plc   1.96 %
Becton Dickinson And Company  1.77 %
Teva Pharmaceutical Industries Limited  1.77 %
Immucell Corporation  1.76 %
Envista Holdings Corporation  1.69 %
Atricure Inc   1.62 %
Black Hawk Acquisition Corporation  1.56 %
Repligen Corp  1.41 %
Omada Health Inc   1.41 %
Arvinas Inc   1.29 %
Pacira Biosciences inc   1.17 %
Waters Corporation  1.12 %
Cormedix Inc   1.11 %
Warby Parker Inc   1.05 %
Surgery Partners Inc   1.02 %
Staar Surgical Co  0.84 %
Biomarin Pharmaceutical Inc  0.82 %
Icu Medical Inc  0.75 %
Lifemd Inc   0.65 %
Radnet Inc   0.50 %
Delcath Systems Inc   0.42 %

Date modified: 2026-09-08T22:25:15+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.